Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment.
about
Developmental transcriptomic features of the carcinogenic liver fluke, Clonorchis sinensisIn-vivo monitoring of development of cholangiocarcinoma induced with C. sinensis and N-nitrosodimethylamine in Syrian golen hamsters using ultrasonography and magnetic resonance imaging: a preliminary study.Possible stem cell origin of human cholangiocarcinomaNervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesisClonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosisNf2/Merlin controls progenitor homeostasis and tumorigenesis in the liverThe role of progenitor cells in repair of liver injury and in liver transplantation.Novel therapeutic strategies for targeting liver cancer stem cells.Oval cell-mediated liver regeneration: Role of cytokines and growth factors.Proteomic identification of potential Clonorchis sinensis excretory/secretory products capable of binding and activating human hepatic stellate cells.Wound healing in the liver with particular reference to stem cellsAltered expression of thioredoxin reductase-1 in dysplastic bile ducts and cholangiocarcinoma in a hamster modelTranscriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.Hepatic progenitor cells in human liver tumor developmentInfection, stem cells and cancer signals.Imaging diagnosis of clonorchiasisChanges in sonographic findings after treatment of patients with clonorchiasis in a heavy endemic area.Progress in stem cell-derived technologies for hepatocellular carcinoma.Development of resistance to reinfection by Clonorchis sinensis in rats.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaPrimary liver tumors: origin and target therapy.Potential applications for cell regulatory factors in liver progenitor cell therapy.Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma.Hedgehog signaling maintains resident hepatic progenitors throughout life.Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.Neoductular progenitor cells regenerate hepatocytes in severely damaged liver: a comparative ultrastructural study.Hepatobiliary inflammation, neoplasia, and argyrophilic bacteria in a ferret colony.The role of p28GANK in rat oval cells activation and proliferation.Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.Animal models of cholangiocarcinoma.Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma
P2860
Q28478834-3AB8F978-F9C6-4EEE-9479-A8E46B794668Q31120998-76546C9C-BEBE-4F69-B665-394DEE4E582AQ33207903-F80DBB16-C395-44FB-8E3A-679588B5619FQ33866778-F1223A62-3B9A-4580-BECC-F2485EB2DD03Q33979981-4FC7D926-BF84-4A59-A59A-B723C253E772Q34069370-3F7243F8-FE1D-43EE-B259-52DA0334B006Q34565292-D4E352B4-A6B7-4A59-93F6-8022B588EAE1Q34940971-0B4574F5-090D-4130-9D88-E3010E7530DFQ35041643-B031DB96-AFFC-4345-8BFC-D5079B89B6E6Q35181015-2B8626A5-C061-4F7D-AD51-B1EC22F3E2BEQ35212061-7F49EE3E-DB8D-4A85-8F6D-6983079CDB4CQ35622366-FE6F0A24-5DD4-4C47-B06C-6FEC1F9FC532Q36279142-61B4E36F-F313-4FFA-9B25-40664A59F777Q36638176-B31F20C8-D6F0-47E7-A209-D8AF8CD6ED19Q36727010-55434936-14BF-4001-B537-4B375B030085Q36850075-0C43F402-4167-4AD9-B9C2-A366B867CFADQ37127521-22BE05AB-B72D-4215-BAFF-BE361CBE6671Q37194065-3B3B0825-341C-45C8-832E-F73ABA7EFF72Q37279500-2AC3CEB8-F7FB-4E58-8A77-CF60B051334BQ37351498-A096CB24-DC0B-4077-BA41-AFE46A84F413Q37552925-F7A715F6-B673-4AC6-AAEB-DFD69C856490Q37790160-D3CB7975-4D05-4F6D-BAD9-EAF580BAC325Q38159684-4AB95078-AD6D-4E26-A70C-1D2E0787CE87Q40085464-9348BE22-1AEF-4A5E-B574-CD99C09847B7Q40345226-34BCBC77-C779-4212-9498-93FA6F917EE4Q40820874-2C9BC9F4-97DD-4655-9667-B30CDDF0F466Q42839188-41EF7833-DFC3-410B-AF4E-C0C3C39A2CE4Q43988417-CD0DE4E7-80D5-4F98-B7D6-5E3C4249C256Q44806456-5B0FDEDB-163B-40D6-B94A-E22A33E1B383Q46920600-3A500B84-AB05-4995-8947-4597D79F3FE2Q47755684-DF040801-21C3-4D72-9C0C-1DC52A108046Q52720960-A63A67BB-21E0-4793-9375-9CA1AF1F8620Q56797178-AEA85EF9-DFAA-4530-85C8-05197CBB0EC6
P2860
Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@en
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@nl
type
label
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@en
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@nl
prefLabel
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@en
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@nl
P2093
P1476
Heterogeneity of the "oval-cel ...... dimethylnitrosamine treatment.
@en
P2093
P304
P356
10.1016/S0168-8278(97)80467-9
P577
1997-06-01T00:00:00Z